Skip to main content

Oregon State Flag An official website of the State of Oregon »

Ballot Measure 110 Savings

UPDATE: House Bill 4002 (2024 Regular Session) repealed ORS 293.665 and 305.231 effective September 1, 2024.  ORS 293.665 directed the Office of Economic Analysis to calculate the savings to the State of Oregon due to the penalty reductions enacted by Ballot Measure 110, while ORS 305.231 directed the Department of Revenue to transfer the calculated amount to the Drug Treatment and Recovery Fund.  Given the effective date of HB 4002, the savings calculated for the 2021-23 biennium (see the brief below) and transferred in March 2024 should remain in effect.  For 2023-25 and beyond, these calculations and transfers are no longer in effect.  This page will remain here for the time being for reference.  If you have any questions, contact Mitchell D'Sa at 971-718-2516 or mitchell.dsa@das.oregon.gov or Michael Kennedy at 971-446-1379 michael.kennedy@das.oregon.gov.


Ballot Measure 110 was approved by Oregon voters in the November 2020 election. BM 110 reduced the penalties for most Possession of a Controlled Substance (PCS) offenses from a felony or misdemeanor to a new Class E violation, punishable with a $100 maximum fine. This change went into effect on February 1, 2021. The Oregon Legislature enacted Senate Bill 755 (2021) to codify and amend BM 110. SB 755 directed the Department of Administrative Services (DAS) to calculate the savings to the State of Oregon from the sentence reductions in BM 110 and further directed the Department of Revenue to transfer those savings to the Drug Treatment and Recovery Services Fund. The document below outlines the methodology for calculating the savings and presents the figures for the 2019-21 biennium.


Other Resources

Chapter 591 Oregon Laws 2021 (see sections 6 and 7 for language pertaining to the transfer of savings and the calculation of savings, respectively)

House Bill 4002 (2024)  - (see sections 72 and 73 of the measure text for language repealing the relevant ORS described above)